You are invited to a Zoom virtual seminar, sponsored by the Latin Comparative Pathology Group. When: Apr 10, 2020 12:00 PM Eastern Time (US and Canada) Topic: Non-clinical Safety Assessment in Human Embryo-derived Stem Cell-Based Therapies: The Long Path for Type I Diabetes and Stem Cells. Our speaker will be Kevin Keane. Kevin is the lead pathologist for the Danish pharmaceutical Novo Nordisk Stem Cell Unit based at the company’s main research campus near Copenhagen, Denmark. Kevin works with his fellow scientists on assessing the safety and efficacy of human embryo-derived stem cell-based therapies for Type I diabetes, Parkinson Disease, Macular Degeneration, and Heart Failure among other diseases. Kevin is involved in the pathology assessment of their in-house efficacy models and external CRO partners. Register in advance for this webinar: https://us04web.zoom.us/webinar/register/WN_qGukxCVUT-iWhXpoKHTyXg <https://us04web.zoom.us/webinar/register/WN_qGukxCVUT-iWhXpoKHTyXg> After registering, you will receive a confirmation email containing information about joining the webinar. If you are unable to attend as an active participant, the seminar will be recorded and available for viewing on the Davis-Thompson Foundation YouTube channel and FB page immediately after its conclusion.